Skip to main content

"We've detected that you're visiting from {0}. Would you like to switch languages for tailored content?"

->

Protecting incisions beyond the OR

Support your patients’ recovery with 3M™ Prevena™ Therapy incision management, to help protect and bolster the incision site, optimise the healing environment of the closed incision, and reduce surgical site complications.

View Clinical Compendium
Prevena Restor™ BellaForm™ Incision Management System Patient can manage therapy at home
Prevena Therapy Proactive Risk Management Specialty areas Devices & dressings Contact us
On this page...
Prevena Therapy
Proactive Risk Management
Specialty areas
Devices & dressings
Contact us

Proactively manage postoperative recovery

In today's healthcare landscape, where complex surgeries and patient comorbidities are prevalent, effective postoperative care is crucial to reduce extended hospital stays, readmissions and to improve overall patient outcomes. The Solventum™ Prevena™ Incision Management System and Solventum™ Prevena Restor™ Incision Management System is intended to manage the environment of closed surgical incisions and surrounding intact skin in patients at risk for developing post-operative complications, such as infection, by maintaining a closed environment via the application of a negative pressure wound therapy system to the incision. The Solventum™ Prevena™ Dressing skin interface layer with silver reduces microbial colonization in the fabric.

  • Protection: Prevena dressings create a barrier against external contamination 
  • Negative pressure: Delivers continuous -125mmHg negative pressure therapy up to 14 days
  • Incision support: Aids in keeping incision edges together, reducing lateral tension 
  • Fluid management: Removes fluids and infectious materials, helping to reduce edema

The Prevena Restor Incision Management System advances original Prevena Therapy expanding NPWT coverage over closed incisions and the surrounding soft tissue to help postoperative recovery. The system introduces new features to improve patient care including:  

  • Expanded coverage: Larger dressing coverage area for the incision and adjacent soft tissue, protecting and bolstering the surgical site and optimising the healing environment  
  • Extended Therapy: The 3M™ Prevena™ Plus Therapy Unit provides 14 days of continuous NPWT
  • Precision design: The dressing adapts to the patient’s body, allowing movement  
  • Versatile application: Intuitive, easy-to-use peel-and-place and flexible, user-customisable dressings available

Prevena Incision Management System: Mechanism of Action

Learn more

Evidence-based proactive risk management

Prevena Therapy can benefit surgical patients — choosing Prevena Therapy can help you manage and protect the incision in patients at risk of postoperative complications. By implementing PRM, you can use procedural and patient risk stratification to help protect your high-risk patients.

View flyer
SSIs occur in 2-5% of all surgical inpatients1 and are a costly complication resulting in:

6X increased likelihood of 30-day readmission2

A graphical representation of a person and arrows continuously circling the person to indicate a strong brand experience. Dark green and teal positive color palette.

$38,656 in additional costs4

Icon illustrating a stack of dollar bills

7-11 days longer stay in hospital1

An iconographic representation of a hospital bed. Dark green and teal positive color palette.

2.2X longer ICU stays2

Icon of a heart with an EKG line going through it.
To help reduce the risk of postoperative complications, Prevena Therapy has demonstrated significant improvement in key outcomes across multiple specialities4, including:

reduction in surgical site complications (SSCs)

46 studies; p<.001

Icon illustration 46%

reduction in surgical site infections (SSIs)

65 studies; p<.001

Icon illustration 47%

reduction in reoperations

40 studies; p<.001

Icon illustration 36%

reduction in readmissions

24 studies; p=.039

Icon illustration 23%

Prevena Therapy for Patients

Are you a patient looking for more information? Visit this helpful website which explains the  Prevena Incision management system, as well as what to expect while a patient is using Prevena Therapy. Patients can find instructions, information on caring for the system, as well as frequently asked questions.

Visit now
Patient recovering at home following knee arthroplasty with PREVENA RESTOR ARTHROFORM. On a virtual consultation with doctor.

Versatile options for your needs

Explore the wide selection of Prevena devices, dressings and kits – uniquely designed to meet the various needs of healthcare providers, surgical procedures and anatomical locations.

Prevena™ Peel and Place Incision Management System

Prevena™ Peel and Place Incision Management System

View product

View product

Contact a Solventum representative

We're here to help! Our team of representatives can provide you with information and resources to help you. Submit the form below to speak with a Solventum representative to learn more about your options.

Looking for customer support? Visit the customer support page.

Fields marked with an * are required.

 

Solventum will use the information to respond to your request in accordance with our Privacy Policy. 

NOTE:

Specific indications, limitations, contraindications, warnings, precautions and safety information exist for these products and therapies. Please consult a clinician and product instructions for use prior to application. This material is intended for healthcare professionals.

Indication(s) For Use / Intended Use:

 

The 3M™ Prevena™ Plus 125 Therapy Unit, when used with 3M™ Prevena™ Dressings (3M™ Prevena™ Plus Incision Management System), is intended to manage the environment of closed surgical incisions and surrounding intact skin in patients at risk for developing post-operative complications, such as infection, by maintaining a closed environment via the application of a negative pressure wound therapy system to the incision.

Limitations :

See full indications and limitations for use at https://eifu.solventum.com/

References :

  1. Anderson DJ, Podgorny K, Berríos-Torres SI, Bratzler DW, Dellinger EP, Greene L, Nyquist AC, Saiman L, Yokoe DS, Maragakis LL, Kaye KS. Strategies to prevent surgical site infections in acute care hospitals: 2014 update. Infect Control Hosp Epidemiol. 2014 Jun;35(6):605-27.
  2. Shepard J, Ward W, Milstone A, Carlson T, Frederick J, Hadhazy E, Perl T. Financial impact of surgical site infections on hospitals: the hospital management perspective. JAMA Surg. 2013 Oct;148(10):907-14.
  3. Costabella F, Patel KB, Adepoju AV, Singh P, Attia Hussein Mahmoud H, Zafar A, Patel T, Watekar NA, Mallesh N, Fawad M, Sathyarajan DT, Abbas K. Healthcare Cost and Outcomes Associated With Surgical Site Infection and Patient Outcomes in Low- and Middle-Income Countries. Cureus. 2023 Jul 26;15(7):e42493.
  4. Cooper HJ, Singh DP, Gabriel A, Mantyh C, Silverman R, Griffin L. Closed Incision Negative Pressure Therapy versus Standard of Care in Reduction of Surgical Site Complications: A Systematic Review and Meta-analysis. Plast Reconstr Surg Glob Open. 2023 Mar 16;11(3):e4722.